KANABO GROUP PLC Logo

KANABO GROUP PLC

Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.

KNB | IL

Overview

Corporate Details

ISIN(s):
GB00BYQCS703
LEI:
213800XPJFSNWJIYKN52
Country:
United Kingdom
Address:
Churchill House, NW4 4DJ London
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kanabo Group PLC is a medical cannabis and wellness company that develops and distributes cannabis-derived products. The company operates a holistic business model, overseeing the entire product lifecycle from research and development to distribution. Its portfolio includes proprietary THC-based medical formulas targeting conditions like CNS disorders, alongside non-THC CBD products for the consumer wellness market. A key innovation is the VapePod®, a medically certified vaporization device designed for precise, metered-dose delivery of cannabis extracts. Kanabo focuses on creating clinically validated, high-quality formulations and has expanded its offerings to include a digital health platform providing patient access to alternative therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-04 08:00
Business and Financial Review
Revenue Growth, Trading and Operational Update
English 19.6 KB
2025-01-06 08:00
Board/Management Information
Directorate Change
English 11.3 KB
2024-11-19 10:55
Report Publication Announcement
The GP Service Wins Award
English 9.2 KB
2024-10-31 10:48
Director's Dealing
Correction Director/PDMR Shareholding
English 27.2 KB
2024-10-29 12:39
Director's Dealing
Director/PDMR Shareholding
English 26.7 KB
2024-09-30 15:50
Earnings Release
Half-year Report
English 307.5 KB
2024-08-28 15:31
Director's Dealing
Director/PDMR Shareholding
English 35.2 KB
2024-06-27 17:49
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 23.0 KB
2024-06-04 08:00
Regulatory News Service
Expansion:14 New Clinics Partnership with Treat-It
English 16.6 KB
2024-05-31 11:30
Pre-Annual General Meeting Information
Notice of AGM
English 12.0 KB
2024-04-30 15:15
Annual Report
Annual Financial Report
English 895.4 KB
2024-03-28 08:00
Business and Financial Review
Expansion of Treat It to Mental Health Treatments
English 14.0 KB
2024-03-27 18:11
Major Shareholding Notification
Holding(s) in Company
English 24.2 KB
2024-03-25 08:00
Legal Proceedings Report
Germany Medical Cannabis Legislation Reform
English 14.0 KB
2024-03-18 10:14
Regulatory News Service
Agritec Update
English 13.9 KB

Automate Your Workflow. Get a real-time feed of all KANABO GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KANABO GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KANABO GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

JEIL PHARMA HOLDINGS INC. Logo
Develops and distributes APIs, generics, and modified drugs, specializing in injections.
South Korea
002620
JETEMA Co.,Ltd. Logo
Research-driven developer of aesthetic toxins, dermal fillers, and threads.
South Korea
216080
Develops and manufactures high-tech drugs for cancer, diabetes, and a range of diseases.
South Korea
007370
JOHNSON & JOHNSON Logo
Develops innovative medicines and medical technologies for complex diseases and personalized care.
United States of America
JNJ
Journey Medical Corp Logo
A pharmaceutical firm commercializing prescription drugs and generics for dermatology.
United States of America
DERM
JUPITER NEUROSCIENCES, INC. Logo
Pharma firm developing resveratrol treatments for neuroinflammation and rare diseases.
United States of America
JUNS
JW LIFESCIENCE CORPORATION Logo
A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.
South Korea
234080
JW SHINYAK CORPORATION Logo
Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.
South Korea
067290
Jyong Biotech Ltd. Logo
Develops plant-derived drugs for urinary system diseases, with a lead candidate in Phase III trials.
United States of America
MENS
Kadimastem Ltd. Logo
Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.
Israel
KDST

Talk to a Data Expert

Have a question? We'll get back to you promptly.